Gastric cancer after Roux-en-Y gastric bypass

Obesity Surgery

Volumn 15, Issue 3, 2005, Pages 423-427

  Escalona, Alex ^a   Guzmán, Sergio ^a   Ibáñez, Luis ^a   Meneses, Luis ^a   Huete, Alvaro ^a   Solar, Antonieta ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Gastric cancer; Morbid obesity; Roux en Y gastric bypass; Stomach

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MONITORING; MORBID OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; STOMACH CANCER; SURGICAL TECHNIQUE;

EID: 16244415905     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892053576668     Document Type: Article

References (28)

1. Mason E, Ito C. Gastric bypass. Ann Surg 1969; 170: 329-39.
2. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004; 350: 1075-9.
3. Raijman I, Strother V, Donegan W. Gastric cancer after gastric bypass for obesity. J Clin Gastroenterol 1991; 13: 191-4.
4. Lord R, Edwards P, Coleman M. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust NZ J Surg 1997; 67: 580-2.
5. Papakonstantinou A, Moutafellos P, Terzis I et al. Gastric cancer occurring after vertical banded gastroplasty. Obes Surg 2002; 12: 118-20.
6. Jain PK, Ray B, Royston CM. Carcinoma in the gastric pouch years after vertical banded gastroplasty. Obes Surg 2003; 13: 136-7.
7. Snook KL, Ritchie JD. Carcinoma of esophagus after adjustable gastric banding. Obes Surg 2003; 13: 800-2.
8. Hackert T, Dietz M, Tjaden C et al. Band erosion with gastric cancer. Obes Surg 2004; 14: 559-61.
9. Buchwald H, Williams Se. Bariatric surgery worldwide 2003. Obes Surg 2004; 14: 1157-64.
10. Sundbom M, Nyman R. Hedenström H et al. Investigation of the excluded stomach after Roux-en-Y gastric bypass. Obes Surg 2001; 11: 25-7.
11. Fobi M, Chicola K, Lee H. Access to the bypassed stomach after gastric bypass. Obes Surg 1998; 8: 289-95.
12. Fobi MAL, Lee H. The surgical technique of the Fobipouch operation for obesity (The transected silastic vertical gastric bypass). Obes Surg 1998; 8: 283-8.
13. Silecchia G, Catalano C, Gentikschi P. Virtual gastroduodenoscopy: A new look at the bypassed stomach and duodenum after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2002; 12: 39-48.
14. Instituto Nacional de Estadísticas (INE). Chile: Anuario de estadísticas vitales, 2001. Available from: www.ine.cl/29-producto/ anuariovitales2001/1/def6_11.pdf
15. Sinar D, Flickinger E, Park H et al. Retrograde endoscopy of the bypassed stomach segment after gastric bypass surgery, unexpected lesions. South Med J 1985; 78: 255-8.
16. Perk H, Sinar D, Sloss R et al. Histologic and endoscopic studies before and after gastric bypass surgery. Arch Pathol Lab Med 1986; 110: 1164-7.
17. Khitin L, Roses R, Birkett D. Cancer in the gastric remnant after gastric bypass: Curr Surg 2003; 60: 521-3.
18. Calle E, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38.
19. Cottam DR, Mattar SG, Barinas-Mitchell E et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
20. Voellinger D, Inabnet W. Laparoscopic Roux-en-Y gastric bypass with remnant gastrectomy for focal intestinal metaplasia of the gastric antrum. Obes Surg 2002; 12: 695-8.
21. Sugiyama Y, Sohma H, Ozawa M et al. Regurgitant bile acids and mucosal injury of the gastric remnant after partial gastrectomy. Am J Surg 1987; 153: 399-403.
22. Ma Z, Wang Z, Zhang J et al. Carcinogenic potential of duodenal reflux juice from patients with long-standing postgastrectomy. World J Gastroenterol 2001; 7: 376-80.
23. Schafer LW, Larson DE, Melton LJ III et al. The risk of gastric carcinoma after surgical treatment for benign ulcer disease: a population-based study in Olmsted County, Minnesota. N Engl J Med 1983; 309: 1210-3.
24. Bassily R, Smallwood RA, Crotty B. Risk of gastric cancer is not increased after partial gastrectomy. J Gastroenterol Hepatol 1990; 37: 392-4.
25. Sundbom M, Hedenstrom H, Gustavsson S. Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study. Dig Dis Sci 2002; 47: 1891-6.
26. Aromaa A, Kosunen T, Knekt P et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142-9.
27. Yoshihara M, Sumii K, Haruma K et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 1090-6.
28. Kitahara F, Kobayashi K, Sato T et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44: 693-7.